Skip to main content

4 Result(s)

within Yukari Hato Remove this filter English Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    HER2 mutation status in Japanese HER2-positive breast cancer patients

    Human epidermal growth factor receptor 2 (HER2) gene amplification/overexpression is a major therapeutic target in breast cancer, and has been introduced as a predictive biomarker to identify patients who may be...

    Yumi Endo, Yu Dong, Naoto Kondo, Nobuyasu Yoshimoto, Tomoko Asano… in Breast Cancer (2016)

  2. No Access

    Article

    Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients

    Tamoxifen can reduce the occurrence of breast cancer by a half in high-risk women. Recently, a genome-wide association study identified two single-nucleotide polymorphisms (SNPs) near or in the CTSO and ZNF423 ge...

    Yukari Hato, Naoto Kondo, Nobuyasu Yoshimoto… in International Journal of Clinical Oncology (2016)

  3. Article

    Open Access

    Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer

    There are many molecular differences between estrogen receptor α (ERα)-positive and ER-negative breast cancers. Recent analyses have shown that the former can be divided into two subtypes, luminal A and lumina...

    Yumi Endo, Hiroko Yamashita, Satoru Takahashi, Shinya Sato… in BMC Cancer (2014)

    Download PDF (597 KB) View Article

  4. No Access

    Article

    Detection of parasternal metastatic lymph nodes by sentinel lymph node methods in a patient with recurrence in the conserved breast

    We herein report a case of second sentinel lymph node biopsy (SLNB). A 57-year-old woman underwent breast-conserving surgery including axillary clearance at Aichi Cancer Center on October 20, 2003. Recurrent t...

    Toshinari Yamashita, Takashi Fujita, Hironori Hayashi, Yoshiaki Ando… in Breast Cancer (2014)